Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Liesbeth, Mieras"'
Autor:
Ephrem Mamo, Robin van Wijk, Anne Schoenmakers, Kidist Bobosha, Mengistu Legesse, Thomas Hambridge, Kitesa Debelo, Fufa Daba, Nelly Mwageni, Abdoulaye Marega, Taye Letta, Ahmed Mohammed Eman, Banú Fumane, Helder Rassolo, Blasdus Franz Njako, Stephen E Mshana, Jan Hendrik Richardus, Christa Kasang, Liesbeth Mieras
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 18, Iss 7, p e0012314 (2024)
BackgroundCase detection delay (CDD) in leprosy is defined as the period between the onset of the first signs and symptoms and the time of diagnosis. A tool, consisting of a questionnaire and a detailed guide for researchers, which includes photos of
Externí odkaz:
https://doaj.org/article/fc3086ec8b9b47769819ab5354c47423
Autor:
Duane C. Hinders, Anneke T. Taal, Suchitra Lisam, Aymée M. da Rocha, Nand Lal Banstola, Prativa Bhandari, Abhijit Saha, Jugal Kishore, Virginia O. Fernandes, Abu Sufian Chowdhury, Anna T. van ‘t Noordende, Liesbeth Mieras, Jan Hendrik Richardus, Wim H. van Brakel
Publikováno v:
BMC Infectious Diseases, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background Leprosy is an infectious disease with a slow decline in global annual caseload in the past two decades. Active case finding and post-exposure prophylaxis (PEP) with a single dose of rifampicin (SDR) are recommended by the World He
Externí odkaz:
https://doaj.org/article/c32fabe1a05e4cbf8beae9c6156433f3
Autor:
Nelly Mwageni, Robin van Wijk, Fufa Daba, Ephrem Mamo, Kitesa Debelo, Benita Jansen, Anne Schoenmakers, Colette L. M. van Hees, Christa Kasang, Liesbeth Mieras, Stephen E. Mshana
Publikováno v:
Tropical Medicine and Infectious Disease, Vol 9, Iss 1, p 18 (2024)
Background: The prevalence of skin diseases such as leprosy, and limited dermatological knowledge among frontline health workers (FHWs) in rural areas of Sub-Saharan Africa, led to the development of the NLR SkinApp: a mobile application (app) that s
Externí odkaz:
https://doaj.org/article/b4da2db25e3f4e90a2fbfe30f76cf996
Autor:
Fleur Ter Ellen, Kaat Tielens, Christine Fenenga, Liesbeth Mieras, Anne Schoenmakers, Mohammad A Arif, Nienke Veldhuijzen, Ruth Peters, Eliane Ignotti, Christa Kasang, Benedict Quao, Peter Steinmann, Nand Lal Banstola, Joshua Oraga, Teky Budiawan
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 16, Iss 10, p e0010792 (2022)
BackgroundIn the past 15 years, the decline in annually detected leprosy patients has stagnated. To reduce the transmission of Mycobacterium leprae, the World Health Organization recommends single-dose rifampicin (SDR) as post-exposure prophylaxis (P
Externí odkaz:
https://doaj.org/article/fc50450ae5a54a7d97d4d721380907f1
Autor:
Kedir Urgesa, Naomi D de Bruijne, Kidist Bobosha, Berhanu Seyoum, Adane Mihret, Biftu Geda, Anne Schoenmakers, Liesbeth Mieras, Robin van Wijk, Christa Kasang, Mirgissa Kaba, Abraham Aseffa
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 16, Iss 9, p e0010695 (2022)
BackgroundLeprosy or Hansen's disease is known to cause disability and disfigurement. A delay in case detection of leprosy patients can lead to severe outcomes. In Ethiopia, the disability rates caused by leprosy among new cases are relatively high c
Externí odkaz:
https://doaj.org/article/497c2e431aeb4ce7b329d7dc7a417a02
Autor:
Astri Ferdiana, Liesbeth Mieras, Pushpendra Singh, Hana Krismawati, Astrid Irwanto, Teky Budiawan, Clara Imaniar, Tri Wahyuni, Arry Pongtiku
Publikováno v:
BMJ Open, Vol 12, Iss 5 (2022)
Introduction The mainstay of leprosy treatment is multidrug treatment (MDT), which contains rifampicin, dapsone and clofazimine. The occurrence of dapsone hypersensitivity syndrome (DHS), a sudden, potentially fatal and traumatic adverse reaction due
Externí odkaz:
https://doaj.org/article/e73ebd042de34e77b07c0f0ab5dccbaf
Autor:
Naomi D de Bruijne, Kedir Urgesa, Abraham Aseffa, Kidist Bobosha, Anne Schoenmakers, Robin van Wijk, Thomas Hambridge, Mitzi M Waltz, Christa Kasang, Liesbeth Mieras
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 16, Iss 1, p e0010038 (2022)
BackgroundDelay in case detection is a risk factor for developing leprosy-related impairments, leading to disability and stigma. The objective of this study was to develop a questionnaire to determine the leprosy case detection delay, defined as the
Externí odkaz:
https://doaj.org/article/2b722e91b28d4bd691584c3fe0a9b92b
Autor:
Stephen E Mshana, Jan Hendrik Richardus, Liesbeth Mieras, Artur Manuel Muloliwa, Anne Schoenmakers, Thomas Hambridge, Robin van Wijk, Christa Kasang, Kidist Bobosha, Fernando Mitano, Ephrem Mamo, Abdoulaye Marega, Nelly Mwageni, Taye Letta, Deus Vedastus Kamara, Ahmed Mohammed Eman, Litos Raimundo, Blasdus Njako
Publikováno v:
BMJ Open, Vol 11, Iss 8 (2021)
Introduction Leprosy, or Hansen’s disease, remains a cause of preventable disability. Early detection, treatment and prevention are key to reducing transmission. Post-exposure prophylaxis with single-dose rifampicin (SDR-PEP) reduces the risk of de
Externí odkaz:
https://doaj.org/article/96cc3cad034940478685bd7823bee9ec
Autor:
David J Blok, Peter Steinmann, Anuj Tiwari, Tanja Barth-Jaeggi, Mohammad A Arif, Nand Lal Banstola, Rabindra Baskota, David Blaney, Marc Bonenberger, Teky Budiawan, Arielle Cavaliero, Zaahira Gani, Helena Greter, Eliane Ignotti, Deusdedit V Kamara, Christa Kasang, Pratap R Manglani, Liesbeth Mieras, Blasdus F Njako, Tiara Pakasi, Unnati R Saha, Paul Saunderson, W Cairns S Smith, René Stäheli, Nayani D Suriyarachchi, Aye Tin Maung, Tin Shwe, Jan van Berkel, Wim H van Brakel, Bart Vander Plaetse, Marcos Virmond, Millawage S D Wijesinghe, Ann Aerts, Jan Hendrik Richardus
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 15, Iss 3, p e0009279 (2021)
BackgroundThe Leprosy Post-Exposure Prophylaxis (LPEP) program explored the feasibility and impact of contact tracing and the provision of single dose rifampicin (SDR) to eligible contacts of newly diagnosed leprosy patients in Brazil, India, Indones
Externí odkaz:
https://doaj.org/article/5a7928a1f2f84d22b9299cdda31d7eb8
Autor:
Jan Hendrik Richardus, ProfPhD, Anuj Tiwari, PhD, Tanja Barth-Jaeggi, PhD, Mohammad A Arif, MD, Nand Lal Banstola, MBA, Rabindra Baskota, MD, David Blaney, MD, David J Blok, PhD, Marc Bonenberger, PhD, Teky Budiawan, MD, Arielle Cavaliero, MPH, Zaahira Gani, MSc, Helena Greter, PhD, Eliane Ignotti, ProfPhD, Deusdedit V Kamara, MD, Christa Kasang, PhD, Pratap R Manglani, MD, Liesbeth Mieras, MD, Blasdus F Njako, MD, Tiara Pakasi, MA, Basu Dev Pandey, PhD, Paul Saunderson, PhD, Rajbir Singh, MD, W Cairns S Smith, ProfPhD, René Stäheli, MSc, Nayani D Suriyarachchi, MD, Aye Tin Maung, MD, Tin Shwe, MD, Jan van Berkel, MA, Wim H van Brakel, PhD, Bart Vander Plaetse, MD, Marcos Virmond, ProfPhD, Millawage S D Wijesinghe, MD, Ann Aerts, MD, Peter Steinmann, PhD
Publikováno v:
The Lancet Global Health, Vol 9, Iss 1, Pp e81-e90 (2021)
Summary: Background: Innovative approaches are required for leprosy control to reduce cases and curb transmission of Mycobacterium leprae. Early case detection, contact screening, and chemoprophylaxis are the most promising tools. We aimed to generat
Externí odkaz:
https://doaj.org/article/c85388dc97ed4ea2b1c56421e7940d48